Cyclic 3′5′ adenosine monophosphate mediates dopamine-enhanced hindgut contractions in the crayfish, Procambarus clarkii

Mode of action of a Drosophila FMRFamide in inducing muscle contraction

Drosophila melanogaster is a model system for examining the mechanisms of action of neuropeptides. DPKQDFMRFamide was previously shown to induce contractions in Drosophila body wall muscle fibres in a Ca(2+)-dependent manner. The present study examined the possible involvement of a G-protein-coupled receptor and second messengers in mediating this myotropic effect after removal of the central nervous system. DPKQDFMRFamide-induced contractions were reduced by 70% and 90%, respectively, in larvae with reduced expression of the Drosophila Fmrf receptor (FR) either ubiquitously or specifically in muscle tissue, compared with the response in control larvae in which expression was not manipulated. No such effect occurred in larvae with reduced expression of this gene only in neurons. The myogenic effects of DPKQDFMRFamide do not appear to be mediated through either of the two Drosophila myosuppressin receptors (DmsR-1 and DmsR-2). DPKQDFMRFamide-induced contractions were not reduced in Ala1 transgenic flies lacking activity of calcium/calmodulin-dependent protein kinase (CamKII), and were not affected by the CaMKII inhibitor KN-93. Peptide-induced contractions in the mutants of the phospholipase C-β (PLCβ) gene (norpA larvae) and in IP3 receptor mutants were similar to contractions elicited in control larvae. The peptide failed to increase cAMP and cGMP levels in Drosophila body wall muscles. Peptide-induced contractions were not potentiated by 3-isobutyl-1-methylxanthine, a phosphodiesterase inhibitor, and were not antagonized by inhibitors of cAMP-dependent or cGMP-dependent protein kinases. Additionally, exogenous application of arachidonic acid failed to induce myogenic contractions. Thus, DPKQDFMRFamide induces contractions via a G-protein coupled FMRFamide receptor in muscle cells but does not appear to act via cAMP, cGMP, IP3, PLC, CaMKII or arachidonic acid.

Dopamine in crayfish and other crustaceans: distribution in the central nervous system and physiological functions

Dopamine is widely distributed in the crustacean nervous system and has a diverse array of physiological effects. Immunocytochemical studies of several species have shown that dopamine- and/or tyrosine hydroxylase-containing cells occur in all ganglia of the central nervous system and that processes from some of these cells link ganglia of the ventral nerve cord. This study describes the distribution of tyrosine hydroxylase-containing cells in the central nervous system of a crayfish (Orconectes rusticus) and compares this information to available data from other species. The distribution of tyrosine hydroxylase (an enzyme in the synthetic pathway between tyrosine and dopamine) in O. rusticus is similar to that reported for marine species. However, differences were observed in the number of neurons in some ganglia and in the axonal projections of the L cell, which were more extensive in O. rusticus than in other species studied thus far. We also review the physiological effects of dopamine in crayfish and other crustaceans, focusing on the amine's actions in the endocrine, cardiovascular, and nervous systems, and on behavior when injected into freely-moving animals.

Differential effects of neuropeptides on circular and longitudinal muscles of the crayfish hindgut

Proctolin (Arg-Tyr-Leu-Pro-Thr-OH) and crayfish peptide "DF(2)" (Asp-Arg-Asn-Phe-Leu-Arg-Phe-NH(2)) enhance spontaneous contractions of isolated crayfish hindguts. Both peptides increase the frequency and amplitude of spontaneous, rapid contractions. Proctolin induces a slow contraction, which gives the appearance of an increase in overall tonus. DF(2) has no such effect. To determine whether the peptides affect both longitudinal and circular muscles, hindguts were cut into longitudinal strips and into rings, and contractions were recorded from each. The longitudinal strips generated only rapid contractions, and both peptides increased the frequency and amplitude of such contractions without significantly altering tonus. Rapid contractions were observed in only 1 of 14 preparations of rings. Proctolin induced slow contractions in the rings, and DF(2) had no such effect. The results indicate that neuropeptides have different effects on circular and longitudinal muscles of hindgut.

Evidence for proctolin-like and RFamide-like neuropeptides associated with the hindgut of the crayfish Procambarus clarkii

Immunohistochemical staining revealed proctolin-like immunoreactivity in nerve endings associated with the hindgut of the crayfish Procambarus clarkii. Proctolin-like bioactivity, detected using both locust oviducts and crayfish hindguts for bioassays, co-eluted with authentic proctolin through five consecutive reversed-phase high-performance liquid chromatography (RP-HPLC) systems. This strongly suggests that proctolin (or a peptide very similar to it) is contained in nerve endings on the crayfish hindgut. RFamide-like immunoreactivity (RFLI) was extracted from the hindguts and intestinal nerves of crayfish and separated using RP-HPLC. Initial separation on a C18 column gave a broad peak of RFLI, and these fractions were bioactive on the crayfish hindgut. Subsequently, RFLI was separated on two additional RP-HPLC systems. The predominant peak could be distinguished from FMRFamide and several known FMRFamide-like peptides on the basis of elution times. Partial sequence analysis indicated the presence of a decapeptide having some sequence homology with leucomyosuppressin and SchistoFLRFamide. These results support earlier evidence that extended RFamide peptides may function as neurotransmitters or neuromodulators on the crayfish hindgut, and suggest a similar role for proctolin or a closely related peptide.